Literature DB >> 29939077

The role of matricellular proteins and tissue stiffness in breast cancer: a systematic review.

Sirio Fiorino1, Salomone Di Saverio2, Paolo Leandri1, Andrea Tura3, Chiara Birtolo4, Mauro Silingardi5, Dario de Biase6, Eli Avisar7.   

Abstract

Malignancies consist not only of cancerous and nonmalignant cells, but also of additional elements, as extracellular matrix. The aim of this review is to summarize meta-analyses, describing breast tissue stiffness and risk of breast carcinoma (BC) assessing the potential relationship between matricellular proteins (MPs) and survival. A systematic computer-based search of published articles, according to PRISMA statement, was conducted through Ovid interface. Mammographic density and tissue stiffness are associated with the risk of BC development, suggesting that MPs may influence BC prognosis. No definitive conclusions are available and additional researches are required to definitively clarify the role of each MP, mammographic density and stiffness in BC development and the mechanisms involved in the onset of this malignancy.

Entities:  

Keywords:  SPARC; breast cancer; matricellular proteins; osteopontin; periostin; stiffness

Mesh:

Substances:

Year:  2018        PMID: 29939077     DOI: 10.2217/fon-2017-0510

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  2 in total

1.  Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment.

Authors:  Karin A Jansen; Antoine Khalil; Peter D Haughton; Thijs Koorman; Daan Visser; Max A K Rätze; Wisse E Haakma; Gabrielè Sakalauskaitè; Paul J van Diest; Johan de Rooij; Patrick W B Derksen
Journal:  Oncogene       Date:  2022-03-15       Impact factor: 8.756

2.  Tubulointerstitial nephritis antigen-like 1 deficiency alleviates age-dependent depressed ovulation associated with ovarian collagen deposition in mice.

Authors:  Masato Akaiwa; Emiko Fukui; Hiromichi Matsumoto
Journal:  Reprod Med Biol       Date:  2019-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.